Doximity (NYSE:DOCS) stock is on the rise after the company’s stellar earnings report for the fiscal first quarter of 2025.
The report reveals an adjusted EPS of 28 cents per share, surpassing Wall Street’s expectations of 23 cents per share. Additionally, the revenue of $126.7 million in fiscal Q1 exceeds analysts’ estimate of $119.9 million, marking a 17% year-over-year increase.
CEO Jeff Tangney expressed his satisfaction with the results, highlighting the record engagement and profits achieved in the last quarter. A record 590,000 unique providers utilized Doximity’s AI, telehealth, messaging, and scheduling workflow tools to enhance patient care.
DOCS Stock Surges on Positive Guidance
Doximity also provided upbeat guidance for fiscal Q2 2025, with revenue projected to be between $126.5 million and $127.5 million, outperforming analysts’ estimate of $123.95 million. Furthermore, the company’s fiscal 2025 revenue guidance of $514 million to $523 million compares favorably to the expected revenue of $512.21 million for the year.
As a result, DOCS stock has surged by 30.1% on Friday morning.
Stay updated on the latest stock market news by checking out the links below!
More Stock Market News on Friday
Disclaimer: The opinions expressed in this article are those of the writer and do not reflect any positions in the mentioned securities. For more information, refer to the InvestorPlace.com Publishing Guidelines.
Source: Wirestock Creators / Shutterstock.com